Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nutra Pharma Corp NPHC

Healthcare Biotechnology
Nutra Pharma Corp. is a holding company, which owns intellectual property and operates in the biotechnology industry. The Company conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer... see more

Recent & Breaking News (GREY:NPHC)

Nutra Pharma Provides Financing Updates and the Elimination of Institutional Debt

Newsfile November 4, 2020

Nutra Pharma Provides Business and Compliance Updates

Newsfile November 3, 2020

Nutra Pharma Provides Updates on Marketing and Distribution

Newsfile March 3, 2020

Nutra Pharma Announces that Nyloxin is Now Available on the iRemedy Marketplace

GlobeNewswire May 30, 2019

Nutra Pharma Responds to FDA Warning Letter

GlobeNewswire April 10, 2019

Nutra Pharma Comments on SEC Complaint

GlobeNewswire September 28, 2018

Nutra Pharma announces updates with EuroAmerican IP & BioArmor, LLC, a Service-Disabled Veteran-Owned Small Business for Sales through GoVets.com

GlobeNewswire September 25, 2018

Nutra Pharma Announces Agreement to Launch Comprehensive Internet Marketing Campaign

GlobeNewswire July 17, 2018

Nutra Pharma Announces Direct Mail Campaign for Pet Pain-Away™ Private Label Brand

GlobeNewswire July 3, 2018

Nutra Pharma Signs Definitive Letter of Intent for $4 Million Joint Venture Financing

GlobeNewswire June 28, 2018

Nutra Pharma Announces Direct Response Television Campaign for Pet Pain-Away™

GlobeNewswire June 6, 2018

Nutra Pharma Partners with NxGen Brands for Nyloxin® Distribution

GlobeNewswire April 19, 2018

Nutra Pharma Files Provisional Patent for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

GlobeNewswire April 10, 2018

Nutra Pharma Announces Corporate Updates

GlobeNewswire March 8, 2018

Nutra Pharma Files Provisional Patent for Nerve Agent Counter Measures

GlobeNewswire February 21, 2018

Nutra Pharma Announces Nyloxin® Distribution Agreement for Australia and New Zealand

GlobeNewswire February 1, 2018

Nutra Pharma Unveils Updated Websites

GlobeNewswire January 25, 2018

Nutra Pharma Partners with EuroAmerican IP to Distribute Nyloxin® for Sale to Government Agencies

GlobeNewswire January 18, 2018

Nutra Pharma Letter to Shareholders

GlobeNewswire December 29, 2017

New Edition of Textbook on Treating Canine Arthritis Includes Nutra Pharma Pain Remedy

Marketwired August 3, 2017